stop use and check batch numbers for infection risk
Tresiba vs semaglutide (Ozempic) Semaglutide is the most prescribed GLP-1 receptor agonist worldwide
Based on todays evidence: Injections produce the highest overall weight loss Oral options offer unmatched convenience with strong early results Both are effective for people with obesity or type 2 diabetes For many patients, the choice is not just which is stronger? But its which is easier to stay on long-term? Side Effects: What the Study Found The clinical trial results for GLP-1 treatments show that orforglipron has a similar side-effect pattern to other GLP-1 receptor agonists: most issues are gastrointestinal and mild to moderate
If people experience nausea while taking GLP-1 injections it may be due to: Delayed Gastric Emptying: Similar to bariatric surgeries, GLP-1 medications slow down the rate at which food leaves the stomach
Known for its benefits in blood sugar management, ginseng has shown promise in animal studies, where it boosted GLP-1 levels in rats with insulin resistance and elevated lipid levels
Most common side effects of orforglipron In phase 2 and phase 3 trials, the most frequently reported side effects were: Nausea Diarrhoea Constipation Vomiting Indigestion/dyspepsia These usually appeared during dose escalation and often settled as the body adjusted
